🌍·7h agoResearch
Efficacy and safety of infigratinib in patients with refractory advanced gastric or gastroesophageal junction adenocarcinoma harboring FGFR2 gene amplification: a single-arm, multicenter phase 2 trial
Publisher
C
Crossref
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Crossref
- Region
- Global
- Scope
- Research
- Published
- June 23, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on doi.org
Leave the platform to read the original full article on the publisher site.
Source: Crossref
Scope: Research
Related coverage
More related coverage
Crossref/7h ago
Clinical and Histopathological Profile of Breast Cancer Based on HER2 Stratification ASCO/CAP 2018: Analysis of HER2-Positive, Negative, Low, and Ultralow
Crossref/7h ago
Garengeot hernia: preperitoneal approach in the context of strangulation, case report
Crossref/7h ago
Does the Use of Liposomal Bupivacaine in Hip Fracture Surgery Have Any Advantage Over Conventional Analgesia for Postoperative Pain Control?
Crossref/7h ago